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Based on the dry powder coating technology platform, this study aimed to develop 
immediate release ginseng chewable tablets using the electrostatic powder coating technique 
and sustained release amino acid pellets using the plasticizer powder coating technique. For 
the immediate release ginseng chewable tablets, the content and types of tableting materials, 
as well as coating materials, coating temperature, curing time and coating level, were 
optimized. For the sustained release amino acid pellets, coating level and curing time, as well 
as the composition of ethyl cellulose (EC), were optimized. In summary, these laboratory 
studies provided new opportunities for additional potential commercial applications for dry 
powder coating technology.  
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Chapter 1  
1 Introduction 
1.1 Pharmaceutical coatings 
Generally speaking, the production process of coated drugs can be seen in Figure 1.1. It is 
usually divided into five parts, including mixing, drying, tableting, coating and final 
packing. 
 
Figure 1.1 The production process of coated drugs 
Coatings are commonly used to make the surface of tablets smoother and in order to 
enhance their appearance, make them resistant to harsh environment (prolonging their 
shell life), or to achieve immediate release, sustained release and delayed release of the 
active pharmaceutical ingredient (API) [1]. 
Among them, immediate release is typically used for veiling taste, identifying via coating 
color (usually green can reduce the patient's anxiety and white can relieve pain), and 
protecting the API from harm by external environment. Sustained release enables the API 
to discharge over an extended amount of time thus delays the remedial impact. Delayed 
release discharges the API at a set time rather than discharge quickly after oral 




Currently, liquid coating technology is commercially used to coati solid dosage forms. In 
general, for water-insoluble materials, a blend of polymers, colors and excipients are 
dissolved in a proper organic solvent to form the solution. Water-soluble polymers can be 
blended into a mixture with colors and excipients and be dissolved or dispersed in the 
water directly. After drying, a dosage form may be sprayed with the solution to create a 
uniform film on the surface. 
However, evaporation of organic solvents or water occupies a large part of the total cost 
of the coating process due to the requirement of heat. Furthermore, a treatment time of 
hours or even several days is crucial for liquid-based coating technologies to obtain a 
uniform and dry surface. Moreover, using organic solvents can increase the risk of 
environmental pollution and explosive hazards. Lastly, in addition to the cost associated 
with long processing time and energy cost for evaporation, the organic solvents 
themselves bring additional costs to the coating process. [2] 
New efforts have been made in recent years to overcome the drawbacks of liquid coating 
technologies such as dry coating technology. Dry coating technologies can be categorized 
as liquid-based or solid-based. Liquid-based methods include both hot-melt and 
photocurable coating. Solid-based coating includes press coating, thermal adhesion 
coating, plasticizer-assisted powder coating and electrostatic powder coating. Among 
these mentioned technologies, dry coating is the most widely studied and has not yet been 
explored. [3] 
Specifically, for the electrostatic coating technology, an electrostatic interaction is 
applied to promote the adhesion of polymers that are not easily film-formable. For this 
coating method, negative and positive charges are introduced to the blended mixture and 
the surface of the tablet and plasticizer is added to decrease the glass transition 
temperature (Tg) of the coating materials. Plasticizer-assisted coating is used directly for 
polymers that are not easily film-formable. 
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1.2 Ginseng chewable tablets 
Ginseng is a slow-growing plant with fleshy roots that has been used for over 2000 years. 
Ginseng is believed to restore and enhance energy, making it one of the most popular 
herbs. People even think ginseng is a panacea and possesses the ability of prolonging life.  
The efficacy of ginseng was known before the 18th century, and the herb has had a long 
history of research. [4] Recently, researchers have revisited the use of biochemistry and 
molecular biology techniques to study ginseng pharmacology. Ginseng and its 
ingredients have been attributed to anti-tumor and anti-stress. It is a herb with many 
active ingredients, and there are numerous studies showing that ginseng does have a 
beneficial effect in treating the conditions mentioned above. [5] 
The active ingredients in most types of ginseng include: ginsenosides (shown in Figure 
1.2 and which is considered as the main ingredient), polysaccharides, peptides, 
polyacetylene alcohols, and fatty acids. [6] However, the amount of ginsenosides in 
different types of ginseng varies widely (2-20%). [7] 
 
 
Figure 1.2 The structure of one special ginsenoside 
American ginseng has been primarily exported to Asia for its value and high level of 
quality since the 18th century. Traditional methods of ginseng consumption include 
stewing, boiling and steaming, but these three methods require a lot of time. Ginseng can 
also be orally taken, but most people are uncomfortable with its bitter taste. A solution 
proposed is to grind ginseng into fine powder (the diameter is less than 40um), add some 
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sweetener to mask the bitterness, and press the mixed fine power into chewable tablets to 
meet the needs of modern fast-paced people. 
Chewable tablets usually contain a certain amount of active ingredients and excipients. 
Excipients include binders to allow better adhesion of various raw material powders, 
lubricants to complete the tableting process, and sweeteners to mask the unpleasant taste 
of the material itself. In addition, the use of a polymer coating makes the surface 
smoother and increases the resistance of the chewable tablets to the external environment. 
Typically, there are two commonly used methods to granulate. Wet granulation uses a 
liquid binder to agglomerate the mixed powder lightly, while dry granulation creates 
pellets by compacting the mixed powder under a certain level of low pressure lightly. 
Ginseng has a similar structure to sawdust which easily leads to the formation of mold in 
the presence of water. For this reason, a dry granulation process is often chosen as the 
method to granulate ginseng. 
Since the ingredients in ginseng are often unpalatable, chewable tablets should be 
flavored to be sweet or sour, giving off a cool sensation while chewing. For this reason, 
the addition of mannitol is considered due to its sweet flavor and ability to easily absorb 
heat in the mouth. Additionally, mannitol has excellent stability, mobility and 
compressibility. Due to its lubricating properties, magnesium stearate is the most 
commonly used lubricant to tablets for prevent ingredients from sticking to the equipment. 
In addition, magnesium stearate is generally safe for human intake under the levels of 
2500 mg/kg per day. Mannitol and magnesium stearate are believed to be appropriate 
materials for the experiment. 
1.3 Amino acid pellets 
Amino acids are organic compounds that contain amino and carboxyl groups. Different 
amino acids are different in the R group. Amino acids are the fundamental substances 
that compose the proteins necessary for animal and human needs. In the form of proteins, 
amino acids are the second largest component in the human body. Amino acids can exert 
several effects through metabolism in the human body such as the synthesis of tissue 
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proteins, conversion to ammonia, hormones, antibodies, creatine and other ammonia-
containing substances, conversion to carbohydrates and fats and oxidation to carbon 
dioxide, water and urea, as well as energy generation. [8] 
The first amino acid which is aspartic acid isolated from asparagus was found in 1806 by 
French chemists Louis-Nicolas Vauquelin and Pierre Jean Robiquet. [9] The last amino 
acid is threonine, which was discovered by William Cumming Rose in 1935. Rose also 
defined the content of essential human amino acids. [10] 
During the beginning of the amino acid industry, protein hydrolysis was often used to 
hydrolyze raw materials such as feathers and pig blood into amino acids. Since the 1960s, 
the industry has placed greater attention on microbial fermentation methods. Compared 
with traditional protein hydrolysis methods, the cost of industrial fermentation methods is 
greatly reduced; helping the amino acid industry develop rapidly. The application of 
amino acids in the industry is mainly used in animal feed additives and food industries, as 
well as in pharmaceuticals and cosmetics. [11] 
In the food industry, a creative idea is to make certain amino acids into sustained-release 
pellets to achieve certain effects within a certain time period. When people perform 
intensive physical exercises, valine can provide additional energy to make the muscle 
produce glucose and prevent weakness; isoleucine can promote the healing of bones and 
damaged muscles; leucine and valine and isoleucine synergistically promotes muscle 
recovery, with valine being the most efficient. Usually, athletes spend 2 to 3 hours of 
intense physical exertion on sports such as football or basketball. However, on the second 
day, they often experience muscle soreness. This situation is unideal for people today in 
terms of both health and work. Therefore, three kinds of amino acids are used according 
to a certain ratio of the mixture to make a complete release of sustained-release pellets 
within 2 to 3 hours. This product can protect an athlete’s muscles during exercise and 




1.4 Objectives and contributions 
The main purpose of this project is to explore the applications of dry powder coating 
technology, including the following aspects: 
First, to realize immediate release ginseng chewable tablets based on dry powder coating 
technology with hydroxypropyl cellulose (HPC) as the coating materials. 
Second, to realize sustained release amino acid pellets based on dry powder coating 
technology with ethyl cellulose (EC) as the coating materials. 
Thirdly, to optimize the processing conditions of dry powder coating including powder 
formulation, curing time, and the ratio of plasticizer to powder to ensure product quality 
while reducing overall cost. 
Finally, these experimental results can be extended and provide new opportunities for 




Chapter 2  
2 Literature Review 
2.1 Types of drug release 
Drug release profiles can be divided into three following types: immediate release 
sustained release and delayed release. Immediate release is also known as conventional 
release, both delayed release and sustained release can be called modified release. 
The types of the drug release typically targets the stability and safety as well as the 
therapeutic profile and efficiency. Three typical drug release profiles are shown in Figure 
2.1. 
 
Figure 2.1 Three types of drug release profiles 
2.1.1 Immediate release 
Immediate release is mostly applied to oral pharmaceutical products, such as tablets and 
capsules that are aimed to release active ingredient immediately without altering the rate 
of drug release after oral administration. Given that immediate-release oral 
pharmaceutical products contain prodrugs, the absorption may be slower due to metabolic 
or biochemical transformation by liver or intestinal metabolism. Alternatively, slow and 
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gradual dissolution or selective absorption in the gastrointestinal tract cannot keep up 
with the rate of drug release, which leads to delayed onset of action. 
2.1.2 Sustained release 
To achieve a better therapeutic effect, the release rate of the drug from tablets or capsules 
should be at a predetermined rate in order to maintain a constant drug level. However, 
some external factors such as pH will affect the drug release rate. 
Sustained release, which is also known as extended release, refers to the system that 
allows the drug to be released over an extended period of time to achieve a prolonged 
therapeutic effect after oral administration by maintaining the level of drug in the blood 
or target tissue. [12] Due to the more flexible formulation design, the route of 
administration of oral sustained release systems has received more attention. There are 
several important and interrelated variables such as the disease being treated, the 
treatment time and the nature of the drug influencing the design of oral sustained release 
system. If the release system can provide some control or be sustained in the time, space, 
or both of the drug release rate in the human body, it is considered a sustained release 
system. [13] Sustained release drug formulations can allow at least a two-fold reduction 
in dose frequency compared to drugs that are presented as immediate (conventional) 
release dosage forms [14].   
2.1.3 Delayed release 
The definition of delayed release is that the release of the active ingredient is at a set time 
instead of immediately after oral administration. Usually, delayed release coating 
prevents tablets passing through low-pH (1.5-3.5) environment (stomach) from being 
destroyed by gastric juice due to high-pH (>6.5) environment (intestinal tract). However, 
once the dosage form reaches the high-pH environment, the release occurs rapidly and 
the profile is similar to the immediate release. [12] 




2.2 Coating materials 
As stated before, the coating aims to enhance the appearance of the tablets or capsules 
(such as making it smoother or colorful), providing the protecting in external 
environments, and achieving functional control with three typical release.  
Initially, sugar was used as the pharmaceutical coating material until the 1950s when it 
was replaced by film coating technology. The main film coating materials are typically 
semi-synthetic copolymers of cellulose derivatives and synthetic methacrylate polymers, 
such as methyl cellulose (MC), ethyl cellulose (EC) and hydroxypropyl cellulose (HPC), 
a cationic copolymer based on dimethyllaminoethyl methacrylate, butyl methacrylate, 
and methyl methacrylate. [15] 
2.2.1 Polymers for immediate release 
Most of the polymers used for immediate release coatings are water-soluble, and their 
rapid dissolution in water ensures the immediate release of active ingredients. 
Hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose (HPMC) and Eudragit® 
E PO (EPO) are three examples of polymer materials for immediate release. 
HPC (Fig. 2.2) is often used with HPMC, but their molecular weight is different, and the 
degree of substitution between methoxy and hydroxypropoxy groups is different as well. 
HPC and HPMC are cellulose ethers, some of its hydroxyl groups have been 
hydroxypropylated to form propylene oxide groups. [16] 
Both HPC and HPMC are widely used in the pharmaceutical field. However, HPC has a 
stronger binding force than HPMC, which makes the film formed by HPC to have better 







Eudragit® E (Fig. 2.3) includes the series of Eudragit® E 100, Eudragit® E PO and 
Eudragit® E 12.5. The series of Eudragit® E is essentially a cationic copolymer.  
The ratio of dimethylaminoethyl methacrylate, butylmethacrylate, and methyl 
methacrylate is 2:1:1 in Eudragit® E 100. Eudragit® E 100 is also the liquid form of 




Along the main chain, monomers are distributed randomly. Based on a size-exclusion 
chromatography (SEC) method, the average molar mass (MW) of the series of Eudragit® 
E is approximately 47,000 g/mol. [17] 
2.2.2 Polymers for sustained release 
Polymers applied in sustained release are aimed at maintaining a consistent level of drug 
in the blood or target tissue after oral administration. Ethyl cellulose (shown in Fig. 2.4) 
Figure 2.2 The structure of HPC 
Figure 2.3 The structure of Eudragit® E 
11 
 
and Eudragit® RL and Eudragit® RS (shown in Fig. 2.5) are commonly used in the 
sustained release. [12] 
Ethyl cellulose has become a widely used film coating polymer for oral sustained release 
dosage forms since 1958. The polymer was originally made into an organic solution, and 
it was later developed into aqueous emulsion dispersions and powders. [18] 
Ethyl cellulose is an ethyl ether of cellulose. Ethyl cellulose can be obtained with the 
reaction of ethyl chloride and alkaline cellulose (treatment of the crude fiber with a lye). 
As with most film coating polymers, ethyl cellulose also has various grades with different 
molecular weights, each grade being expressed by its viscosity value. [19] 
 
 
Figure 2.4 The structure of ethyl cellulose 
Eudragit® RL and Eudragit® RS are acrylates and methacrylates, which have some 
hydrophilicity because of the quaternary ammonium groups (trimethyl-ammonioethyl 
methacrylate chloride) (shown in Fig.2.5). [20] They are insoluble in water but become 
permeable and swelled in the presence of digestive fluid without the effect of pH. They 
are generally used in matrix formulations for film coating of tables, capsules and pellets. 
[21] 
The content of quaternary ammonium groups is the only difference in the two polymers. 
In Eudragit® RL, the molar ratio of quaternary ammonium groups to neutral methacylic 
acid ester groups is 1:20. However, it is 1:40 in Eudragit® RS. Thus Eudragit® RL has a 




Figure 2.5 The structure of Eudragit® RL and Eudragit® RS 
2.2.3 Polymers for delayed release 
The most commonly used polymers for delayed release are cellulose-based and 
mathacrylate-based polymers. These polymers protect the active ingredient from damage 
in a low pH external environment such as the stomach (pH 2-3). Meanwhile, the 
polymers can dissolve immediately in high pH zone, such as the small intestine with the 
pH of 6.5-7, and the colon with the pH of 7.0-8.0. [23] 
Currently, the series of Eudragit® including L100-55, S100 and L100 are the three 
typical polymer powders mostly used for delayed release. Eudragit® L100-55 (shown in 
Fig.8) is also named Acryl-EZE and dissolves above the pH of 5.5. L 100, (shown in Fig. 
2.6), which dissolves above the pH of 6.0, and S 100, which dissolves at a pH level of 
over 7.0, are anionic copolymers. In the series of L 100, the ratio of free carboxyl groups 
to the ester groups is approximately 1:1. However, it is 1:2 in Eudragit® S 100. Along the 
main chain, the monomers are distributed randomly. Based on the size-exclusion 
chromatography method, the average weight molar mass (Mw) of the series of Eudragit® 





Figure 2.6 The structure of (a) Eudragit® L 100 and (b) Eudragit® L 100-55 in low 
pH (1-2) 
2.2.4 Plasticizers 
In general, a typical plasticizer is a water-insoluble material with low molecular weight 
(200-1000g/mol). Plasticizers are used as a non-volatile additive to incorporate 
themselves between/in the polymer chains, increasing the free volume to improve the 
flexibility and processability of polymers by lowing the glass transition temperature (Tg). 
[25] The falling value of Tg compared with the original Tg can be used as a factor that 
characterizes plasticization efficiency. [26] 
In the pharmaceutical coating industry, triethyl citrate (TEC, shown in Fig. 2.7) and 
polyethylene glycol 400 (PEG400) are most commonly used due to stable performance 
and relatively low prices. 
 
Figure 2.7 The structure of TEC 
TEC is better combined particularly with immediate release materials and delayed release 
materials, such as EPO, Eudragit® series including L 100-55, L 100 and S 100. PEG 400 
shown in Fig. 2.8 is more suitable with sustained release materials such as Eudragit® RL 




Figure 2.8 The structure of PEG 400 
When incorporated between/in the polymer chains, plasticizers increase the separation of 
polymer molecules, forming the free zone to improve the flexibility and processability by 
decreasing elastic modulus, tensile strength and Tg. [29] This leads to the realization of 
lower heat treatment. In addition, plasticizers increase the electrical conductivity to 
attract more powder depositing on the surface of the tablets or pellets, thus increasing the 
efficiency of powder materials in the electrostatic dry coating technique. [27,30] 
Two key parameters will be considered when choosing a suitable plasticizer. One is the 
compatibility with the polymer, which is that coating polymers should have high 
solubility in the plasticizer. [31] The second is the plasticization efficiency, since only a 
reasonable amount of plasticizer with polymer can form a uniform and continuous film. 
An excessive amount plasticizer leads to the leakage of plasticizer on the surface of film 
and cause it to become brittle. Ultimately, considering polymer compatibility and a 
suitable plasticizer ratio is a critical process in film coating. [32] 
Although traditional plasticizers are usually liquid, the concept of solid plasticizers is 
now proposed as an alternative. Solid plasticizers act as auxiliary plasticizers and are 
most typically used in conjunction with a primary liquid plasticizer. Their main role is to 
promote the plasticization of polymer materials and to suppress the precipitation of the 
primary plasticizer. 
A typical solid plasticizer used in this experiment is lactose (Fig. 2.9). Lactose is a 
disaccharide composed of galactose and glucose. Usually, milk contains 2 to 8 % total 
weight of lactose. Lactose has good water solubility and a faint sweetness, so it is often 




Figure 2.9 The structure of lactose 
2.3 Solvent-based coating 
Solvent-based coating methods, including sugar coating, organic solvent coating and 
aqueous-based coating are widely accepted and used in modern pharmaceutical coating 
processes. The sugar coating pharmaceutical process was first invented in the United 
States in 1856, which is still a widely used technology, although people have payed 
attention to film coating technology since the 1950s. Due to its more environmentally 
friendly properties, aqueous film coatings have replaced some organic solvent coatings. 
[33] 
2.3.1 Sugar coating 
In sugar coating equipment, tablets or capsules are treated with sugar solution containing 
pigments or certain functional ingredients, the degree of treatment is dependent on the 
required coating level. The sugar coating industry is labor-intensive relative to film 
coatings. Firstly, the sugar coating process requires many laborers to handle the multi-
step process. Secondly, there needs to be highly skilled laborers to properly perform the 
operations of the process.  
Several advantages are considered when choosing sugar coating. Sugar is a cheap and 
easily available material and widely accepted by public, which can avoid regulatory 
issues. Compared with film coating equipment, sugar coating equipment is less 
complicated. 
A downside of sugar coating, however, is that tablet cores need to be softer than that in 
film coating. In addition, a whole sugar coating process usually will last for several days. 
16 
 
Thus, today's pharmaceutical industry has suspended the development of sugar coating 
process due to its long-time treatment and labor force. 
2.3.2 Organic coating 
Like the sugar coating, the color or some of the functional ingredients are dissolved in the 
organic solution, and the tablets are dried after the solution is sprayed on the surface to 
obtain a dry and uniform film. The schematic of organic solvent coating can be seen in 
Fig. 2.10. Conversely, unlike sugar coating, the use of an organic solvent coating process 
reduces the requirements of labor and the level of operation when compared to the sugar 
coating process.  [34] 
 
Figure 2.10 The mechanism of organic solvent coating 
Organic solvent coating is still the primary choice for the coating industry due to the 
stability and maturity of the technology. However, it still has several disadvantages. First, 
the organic solvent coating needs to be dried to obtain the desired film. This process 
requires a lot of time and energy, which leads to an increase in cost, and an increase in 
temperature which, concordantly, increases the risks associated with the inactivation of 
the active ingredients. Second, achieving different release profiles often requires multiple 
sprayings, which makes the process more complicated. A non-uniform coating results in 
a decrease in stability and efficacy of the production. Due to these shortcomings, the 
solvent-free coating technology has received more and more attention. [34] 
2.3.3 Aqueous coating 
The study of water-based coating technology began in the early 1970s with the 
development and utilization of a series of water-based coating materials. [35] The rapid 
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development of fluidized-beds, high-efficiency coating pans and other technical 
equipment also promoted the development of this technology. For the stability of the film 
and coating uniformity, water dispersion materials are generally diluted by the principle 
of compatibility to reduce the solid content to 16% from 24% before use. To change the 
release rate and improve certain properties of aqueous dispersions, the amounts of 
excipients such as plasticizers, anti-adherents, porogens, and the drug channels need 
regulated. [36] 
Alginic acid propylene glycol can be added to the coating material to study the stability 
of the membrane to increase the stability. Aqueous dispersion formulation can be made 
by biological materials, such as nano-ploymers.. As shown in Fig. 2.11, the dispersion 
and water were deposited on the drug surface during the formation of the film. After the 
water begins to evaporate, the polymer particles begin to compact and deform. Finally, 
after the water is completely evaporated, the polymer particles are interconnected and 
form a film. [32] 
 
Figure 2.11 The mechanism of aqueous coating 
Water coating technology began because of people’s increasing level of attention to 
environmental protection and the rise of organic solvent price. Substituting water for 
organic solvents can avoid organic solvent emission to the outside during the coating 
process, avoid the occurrence of flammable and explosive, reduce the cost of itself and 
investment of the recycle system, and eliminate the damage to the operator caused by 
organic solvents. [33] However, due to its full-water properties, unique film formation 
mechanism and other factors, there are also certain problems in practical applications. 
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Some polymers have poor dispersion in water, which can lead to clogging of spray 
nozzles. Furthermore, if the active ingredient is sensitive to moisture, residual moisture in 
the film can cause inactivation of the active ingredient. [37] 
2.4 Dry coating 
In view of some inevitable drawbacks in solvent coating process, today’s pharmaceutical 
coating industry has given rise to several dry/solvenless coating technologies. Time in 
both drying and spraying and cost due to the evaporation of solution decrease 
significantly when using dry coating technologies. 
Dry coating techniques are generally split into two types. One is liquid-based techniques, 
including hot-melt coating and photocurable coating. The other one includes press 
coating, thermal adhesion coating, plasticizer-assisted powder coating and electrostatic 
powder coating, which is known as solid-based techniques. 
2.4.1 Liquid-based coating  
Hot-melt coating 
The hot-melt coating is mainly used in the pharmaceutical coating industry to improve 
the stability of the drug to the external environment, mask the taste of the drug itself and 
realize a sustained release. [38] As its name suggests, a typical hot-melt coating consists 
of four steps: preheating substances, heating the desired coating material to a molten state, 
then spraying it onto the surface of the substance, and cooling under controlled conditions 
to obtain a uniform film. This process usually uses a fluidized bed or a rotating pan to 
produce coated pellets. [39] 
Because of the need of both melting and cooling processes, temperature is the core 
parameter in the hot-melt coating process and need to be tightly controlled in any 
equipment. During the spraying process, the temperature of the material needs to be kept 
40-60℃ higher than the melting temperature of the material. [40] Therefore, the material 
must be heated in the pipe from the reservoir to the nozzle to avoid cooling and clogging. 
[41] The nozzle also needs to be specially designed, such as a triaxial nozzle, shown in 
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Fig. 2.12, to prevent the deposition of droplets in the nozzle. The hot melt material must 
have a low melting point, stability in both physical and chemical states, good flowability 
to be sprayed easily. Fatty acids, partially hydrogenated vegetable oils (mostly palm oil, 
but also soybean oil and cottonseed oil), paraffin wax and polyethylene glycol are 
common hot-melt coating materials. [42] 
 
Figure 2.12 The actual device of nozzle for hot-melt coating [42] 
(a) Melted coating material. (b) Nebulizing airflow. (c) Heated compressed air. 
The hot-melt coating is very effective for small dosage applications, such as small 
particles and pellets. At the same time, this technique saves time if a suitable low melting 
coating polymer is available. However, many cores with active ingredients cannot 
tolerate the temperature at which the material is melted, which can lead to inactivation or 
decomposition of active ingredients. In addition, so far, there are not many materials 
available for selection, which further restricts the production of high-quality coated 
products produced by the hot-melt coating process. 
Photocurable coating 
The photocurable coating method provides a chemical method to achieve the coating 
layers. That is, using a radical polymerization reaction in the presence of a 
photosensitizer and at a lower temperature to form a mutual indirect network and then 
turns into a film in a very short time. [42] 
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The photocurable coating process needs to be equipped with a light source that can 
provide ultraviolet-visible light and a nitrogen purging system to avoid damaging the 
formed film due to the presence of oxygen after the reaction. Wang and Bogner 
introduced a dry photocurable coating method into the pharmaceutical field, where a 
stable film is obtained with nonpareil beads under conditions similar to conventional pan 
coating. [43] 
The photocuring coating method is characterized by low operating temperature and short 
processing time compared to other dry coating methods, and therefore is very suitable for 
photosensitive materials. However, due to toxicological limitations, photocuring coating 
materials are generally not recognized as safe, limiting their application in the 
pharmaceutical field. [44,45] 
2.4.2 Solid-based coating 
Press coating 
The press coating technique (or compression technique) utilizes compressive force to 
achieve a coating layer. First, the tableting mold is filled halfway with the coating 
material powder. Afterwards, the core is placed into the center of the tablet, filling the 
remaining half of the coating material powder into the mold and compresses to obtain a 
film with a certain level of thickness. The press-coated tablet can be seen in Fig. 2.13. [45] 
 
Figure 2.13 The press-coated tablet 
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In press coating, the outer film has a great influence on the mechanical strength and 
stability of the product. At the same time, the position of the inner core needs to be 
exactly in the center of the product. [46,47] Therefore, as an improved method, a one-step 
manufacturing method is proposed based on an equipment with special design. In this 
process, the product can be used for delayed release, and adjustments to the thickness of 
the film can control the release profile. [48] 
Most of the press coating materials are selected to have hydrophilic and expandable 
polymers, such as cellulose derivatives, including hydroxypropyl methylcellulose 
(HPMC), hydroxy ethlcellulose (HEC) and hydroxypropyl cellulose (HPC). [49,50] In 
addition, these polymers are degradable and of low cost. 
However, the compression coating is limited by the thickness of the coating, and there are 
less active ingredients that can be utilized in this technology in comparison with other dry 
coating technologies. This reduces the production efficiency, especially for some smaller 
particles and pellets. 
Thermal adhesion powder coating 
Thermal adhesion powder coating (or heat-drying coating) utilizes thermal reaction to 
achieve a powder coating film. The coating powder is a mixture of a polymer, which had 
been plasticized beforehand and then milled in a room or lower temperature after the hot 
melt extrusion process, and talc powder (added to prevent sticking between powders and 
powders and walls). Therefore, the thermal properties of the coating powder are of great 
importance in the thermal adhesion powder coating technology. [51] 
In a typical thermal adhesion coating process, the plasticizer content can reach up to 40% 
of the total weight, and requires a long curing period to ensure the film's uniformity and 
stability. The application of the thermal adhesion coating described in the literature 
mostly uses an acrylic polymer and a modified rotating pan. The designed rotating pan 
adds a centrally located powder feeder and an infrared heating device at the top. The 
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Plasticizer-assisted powder coating 
In the plasticizer-assisted powder coating technique, plasticizers and powders are added 
simultaneously or alternately from two different feeders, obtaining a uniform film after a 
certain period of curing. A typical device is a traditional rotating pan or a fluidized bed 
equipped with nozzles, or a three-way nozzle inserted into the device to transport liquids 
and powders. [53,54] 
The main purpose of the plasticizer-assisted powder coating is to reduce the glass 
transition temperature (Tg) of the coating material. The plasticizer and coating polymer 
are combined to increase the free volume within the polymer molecular, resulting in a 
glass transition temperature lower than the curing temperature. This is also a precondition 
for forming a film. Due to its performing operation at a lower temperature, the active 
ingredients of the drug are protected. [55,56] 
Triethyl citrate (TEC), polyethylene glycol 400 (PEG400) and acetylated monoglycerides 
(AMG) or their mixtures are commonly used as liquid plasticizers. [57] However, some 
Figure 2.14 The outline of solid-based coating techniques 
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plasticizers may only be effective in a mixture with certain polymers. While the 
plasticizer-assisted powder coating technique is not specifically required for the coating 
substance, as it can be large tablets or small particles, a rotating pan is generally suitable 
for large tablets and a fluidized bed is used for small particles to avoid the adhesion 
between particles and between particles and walls. This technology has been applied to 
achieve immediate release, sustained release and delayed release. [58-60] 
The control of the amount of plasticizer and a higher coating level presents certain 
drawbacks to this technology. The addition of too much plasticizer can result in adhesion 
between particles and between particles and walls, and the addition of too little plasticizer 
can cause an uneven film. Moreover, when compared to liquid coating, this technique 
usually requires a higher level of coating to achieve the same effect. 
Electrostatic powder coating 
Electrostatic powder coating has become very mature in the metal surface treatment 
industry, and an improved plasticizer-electrostatic-thermal powder coating has begun to 
be applied to pharmaceutical coating industry. [61] As its name suggests, plasticizers are 
used to lower the glass transition temperature (Tg) and increase the conductivity of the 
tablets or pellets. Electrostatic force is used to increase force between the powder and the 
coating substance, which is usually achieved by applying negative electrons to the 
coating material. The rotating pan is grounded and equipped with an electrostatic gun. 
After the coating materials are deposited onto the solid dosage surface, the electrons are 
released to the ground through the grounded rotating pan, and the powder forms a 
uniform film after a certain time of thermal reaction. [62] 
In general, the process begins with the solid dosage form preheated to a target 
temperature at a low speed in a rotating coating pan. Next, at a higher rotational speed, a 
certain amount of plasticizer is evenly and discretely sprayed onto the solid dosage 
surface, followed by amount of mixed powder sprayed from an electrostatic gun. The 
rotating speed is reduced to allow the solids to form a uniform film at a certain 
temperature and time. In general, achieving a stable and uniform film requires repeating 
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this process many times. This technique has been successfully applied to control 
immediate release, sustained release and delayed release. [63] 
Electrostatic powder coating does not use organic solvents, which avoids the pollution 
and the cost of evaporating associated with the solvent. At the same time, the 
disappearance of water makes this technology applicable to water-sensitive materials. 
However, this technology still has some limitations due to the precondition of static 
electricity, and coating substances with low-conductivity being inefficient. 
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Chapter 3  
3 Materials and methods 
3.1 Materials  
3.1.1 Ginseng powder 
Ginseng powder was provided by Mary Ginseng House. (Canada). 
3.1.2 Amino acid pellets 
The amino acid pellets were donated from MERRIN (Ningbo) Biotechnology Co., Ltd. 
The composition of the amino acid pellets can be seen in Table 3.1. 
Table 3.1 The composition of the amino acid pellets 




hypromellose (HPMC) max 5% 
3.1.3 Coating and tableting powders 
Eudragit® E PO and Colloidal silicon dioxide (AEROSIL® 200 Pharma) were provided 
by Evonik Degussa Corporation (Germany). Magnesium stearate was from 
GlaxoSmithKline (UK). HPC was from Avantor Performance Material, Inc. (US). Talc 
powder was from Bulk Pharmaceutical Chemical. (US). Mannitol (PEARLITOL® 100SD) 
and sorbitol powder (NEOSORB® P110) were provided by ROQUETTE, Inc. (US). 
Copovidone (PLASDONE® S-630) was provided by ISP TECHNOLOGIES, Inc. (US). 
EC was donated by Colorcon. Inc. Lactose was from Foremost Farms USA Cooperative. 




Polyethylene glycol 400 (PEG 400) was donated by Acros Organics. Inc. (US). Triethyl 
citrate (TEC) was from Alfa Aesar. Inc. (US). 
3.2 Particle size reduction and analysis 
When the powders are manufactured, they are cooled, then the large pieces are grounded, 
and finally sieved to the powder with a specific particle size required by the manufacturer. 
In general, fine particles facilitate jetting by the spray gun and fluidization in the 
fluidized bed. In addition, smaller particles have more filled voids on the surface of the 
coating, making the resulting film denser and more uniform. If the particles are too large, 
aside from affecting the compactness of the film, fine spots will be formed on the surface 
of the drug, thus affecting the appearance. 
Choosing the right particle size to achieve a dense and uniform film during the coating 
process is crucial. However, many of the materials obtained from suppliers do not 
precisely match specific needs. In this frequent case, the particles need to be grounded 
and subjected to ultrasonic sieving (HK Technologies Ultrasonics Rugby, United 
Kingdom) before use. 
After particle size reduction, particles will be characterized by a laser particle size 
analyzer (TSI Corporation, Model 3603, Shoreview, MN, USA). Fraunhofer diffraction 
theory is the basis of laser diffraction analysis. In the propagation of light, the front 
waves are limited by apertures or particles that are equivalent to the wavelength scale, 
and the diffraction is generated by spatially interfered the emission originated from the 
elementary waves at the confined front wave. The spatial (angle) distribution of scattered 
and diffracted light energy is related to the wavelength of the light wave and the 
dimensions of the pore or particle. With a laser as the light source, the spatial (angle) 
distribution of the diffracted and scattered light energy is only related to the particle 
diameter after the light has a monochromatic beam with a certain wavelength. The 
diffraction of the particle group determines how much each particle level corresponds to 
the light energy obtained at each particular angle. The proportion of each specific light 
energy in the total energy amount should reflect the abundance of each particle level. 
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The volume mean diameter (D [4,3]) was used to describe the average particle size. The 











The average particle size of coating powders is shown in Table 3.2. Each size was 
measured three times. 
Table 3.2 The average particle size of coating powders 
Coating powder Average particle size, D [4,3] (μm) 
Eudragit® E PO (EPO) 13.3 




3.3 Angle of repose (AOR) 
The angle of repose of the powder is the angle at which the powder can accumulate but 
does not collapse. The density, shape and friction coefficient of the particles can be 
reflected by the number of angle of repose. 
The fixed funnel machine (Hosokawa micron corporation, JAP) was used to determine 
the angle of repose. The ginseng mixed powder was poured through a funnel until a cone 
was formed. The top of the funnel should be close to the cone as much as possible to 
reduce the effect of falling particles. When the cone reached a predetermined height and 
the side reached a predetermined width of the base, pouring of the powder was stopped. 
The tangent of the height divided in half the width of the bottom of the cone results in the 
angle of repose. 
A diagram of the angle of repose can be seen in Figure 3.1. where r is the radius of the 




Figure 3.1 The diagram of the angle of repose 
3.4 Tableting 
Tableting is the process of compressing mixed powder into tablets of a certain size and 
weight. During the tableting process, the lower punch partially extends into the die hole 
and seals the bottom of the die hole. At the same time, a feeder is used to fill the die hole 
with the drug, the excess drug is scraped off from the top of the die, and the upper punch 
is pressed from the upper end to the die hole and descends a certain distance to compress 
the powder into a piece. Afterwards, the upper punch is lifted from the hole and lower 
punch upwards to eject the tablet out of the die hole to complete the pressing process. 
Finally, the lower punch falls to its original position where it stays until the next tableting 
cycle. 
The tableting machines required for the tableting process include single punch tableting 
machines and rotary tableting machines. Normally, the number of tablets is the main 
factor for selecting a suitable tablet press. A single tableting machine can compress 60 
tablets per minute, while a rotary tableting machine, the schematic of that can be seen in 
Fig. 3.2, can compress 1,000 tablets per minute. In this experiment, the ginseng chewable 
tablets (diameter is 1.5cm and thickness is 0.25cm) were prepared using a single-punch 
tableting machine (GeXin motor factory, model G-7114, Shanghai, China) and the lactic 
acid tablets (diameter is 0.7cm and thickness is 0.20cm) that assisted the ginseng 
chewable tablets in the coating process used a rotary tableting machine (TianFan 




Figure 3.2 The schematic of a rotary tableting machine 
3.5 Scanning electron microscope (SEM) 
Scanning electron microscopes use the secondary electron signal imaging to observe the 
surface morphology of samples. The samples are scanned by a raster scan mode using an 
extremely narrow electron beam. The number of secondary electrons that can be detected 
depends on the morphology of the sample.  
Through scanning the samples and collecting the emitted secondary electrons using a 
special detector, the surfaces of the samples can be generated through the formation of 
images. Since the secondary electrons are emitted very close to the sample surface, the 
SEM can produce high resolution images of the sample surface, even displaying sample 
details less than 1 nm. 
In this experiment, An EMITECH K550 coater (Emitech Ltd., Ashford, UK) was 
employed to coat the samples. After being coated, the samples were observed under a 
scanning electron microscope at 5.0 kV (SEM, Hitachi S-2600N, Ontario, Canada). 
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3.6 Hardness test 
The hardness of the tablet plays an essential role in the quality control of the product. 
High hardness tablets require the addition of more lubricants and compressible 
substances to the tablet formulation, which reduces the active ingredient content. At the 
same time, if the hardness is too great, the disintegration time of the tablet will be longer, 
and the release curve will be affected. On the other hand, if the hardness of the tablets is 
too low, the tablets will be more brittle, which will affect the subsequent coating process 
and transportation of the tablets. 
Hardness testing of tablets is a widely used laboratory testing method. A hardness test 
machine (Tianjin GuoMing medicinal equipment Co., Ltd, model YD-1, China) was used. 
Tablets are usually placed between two flat plates, one of which is connected to a 
pressure sensor and the other is connected to a motor that provides a driving force. In the 
hardness test, the motor drives one plate close to the other until the tablet breaks and the 
pressure sensor records the hardness of the tablet. In general, the hardness of a 500mg 
chewable tablet is about 60 N. 
3.7 In-vitro drug release testing 
In-vitro drug release tests of the coated samples were runed by the United States 
Pharmacopeia (USP) apparatus (Apparatus 2, paddle; Huanghai Rcz-6c2, Shanghai, 
China). For EPO-coated ginseng chewable tablets, the drug release medium is 900 ml of 
pure water maintained at 37°C with a paddle rotating speed of 50 rpm. For the EC coated 
amino acid pellets, the drug release medium is 1000 ml of pure water maintained at 37°C 
with a paddle rotating speed of 50 rpm.  
In this process, 10 ml of the sample was collected through a 10ml syringe over a certain 
period of time, and 10 ml of fresh medium (pure water) was immediately supplemented. 
After 10 ml of the sample was filtered, it was analyzed using a UV-Visible 
spectrophotometer. The maximum absorption wavelength of the analyzed component in 




3.7.1 Standard curve 
The drug dissolution profiles of ginseng chewable tablets and amino acid pellets can be 
seen in Figures 3.3 and 3.4, respectively. The curve is used to determine the 
concentration of the sample obtained from the dissolution test. 
 
 
Figure 3.3 Standard curve of ginseng chewable tablets 
 

























Figure 3.4 Standard curve of amino acid pellets 
3.7.2 UV-Vis spectrophotometer validation 
After the creation of the standard curve of ginseng chewable tablets and amino acid 
pellets, a precision test, accuracy test and a stability test are required for the acceptability 
validation of the application of UV-vis spectrophotometer that is used for the 
measurement and analysis of the drug release from ginseng chewable tablets and amino 
acid pellets. 
Precision test 
Two solution samples of the ginseng chewable tablets and amino acid pellets were 
prepared. These samples have a concentration lower than the maximum standard 
concentration curve and were scanned. The input concentrations of the UV-VIS 
spectrophotometer and known concentrations determined the standard error and precision 
testing. When the standard error is less than 1%, this test is considered successful. 



























𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑠𝑎𝑚𝑝𝑙𝑒




Configure three samples of high, medium, and low concentrations, and then scan each 
sample. Within a certain confidence interval, the difference between the actual 
concentration of each sample and the average number of the test is the accuracy test of 
this sample. 
Percentage Difference =




In the stability test, known concentrations of ginseng chewable tablets and amino acid 
pellets solution samples that are less than the maximum concentration of the standard 
concentration curve were placed in a dissolution at 37°C. Samples were taken with a 
10ml syringe for a certain of periods (0 hours, 1 hour, 2 hours, 6 hours, 12 hours), and 
then subsequently scanned. Using the initial concentration as a base, if the difference 
between the sample concentration at 12 hours and the base concentration is minimal, the 
release may be deemed stable. 
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Chapter 4  
4 Electrostatic Powder Coating of Ginseng Chewable 
Tablets 
4.1 Apparatus and experimental procedures 
4.1.1 Apparatus 
The rotating coating pan designed by the research group was applied to the coating of 
chewable ginseng tablets. The schematic diagram of the rotating coating pan can be seen 
in Fig. 4.1. It consists of four parts: an incubator that guarantees a constant temperature 
and even heating of the coating pan. A circular outer coating pan with an oval inside 
(with a diameter of 12.8cm and a depth of 12.8cm) sits within the incubator. There are 
four wavy prisms inside the pan. The irregular movement caused by the prism and ellipse 
accelerates the tumbling of the tablets inside the pan, making the tablets coating more 
uniform. In addition, the liquid plastic spray system includes a metering pump and an 
atomizing nozzle. The powder coating apparatus includes an electrostatic generator at the 
spray gun and a nozzle. The temperature of the entire system and the rotational speed of 
the rotating coating pan can be well controlled.  
 
Figure 4.1 The schematic of rotating coating pan for ginseng chewable tablets.  
(A) Liquid plasticizer spraying system. (B) Rotating coating pan. (C) Electrostatic 
spraying gun. (D) Powder feeder 
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4.1.2 Experimental procedures 
The process of coating the ginseng chewable tablets with a rotary coating pan is divided 
into five steps, including: preparing the coating powder, preheating the tablets and 
equipment, spraying the liquid plasticizer, spraying the coating material, and curing the 
tablet film. 
The first step is preparing the tablets coating materials. The coating material (Eudragit® 
E PO or hydroxypropyl cellulose) is mixed with the additives (talc, color, colloidal 
silicon dioxide and pigment) into a homogeneous formulation until there is no significant 
agglomeration or color difference. 
The second step is to place a certain amount of ginseng chewable tablets and placebo 
tablets (total weight is 50g) in a rotating coating pan, set a temperature exceeding the 
glass transition temperature, and rotate the coating pan at a slow speed. 
The speed is then increased to avoid sticking of the tablets surface when spraying the 
plasticizer and coating material. After spraying the plasticizer for a certain period, a 
certain weight of coating material is sprayed immediately, and the rotating speed is then 
lowered. These two steps are usually repeated multiple times every 10-20 minutes. 
The curing step begins when sufficient coating material is attached to the tablet surface. 
To prevent sticking, talc powder is usually added, and the ginseng powder can also be 
added to make ginseng chewable tablets full of ginseng taste. The rotation speed is 
decreased and the temperature is kept stable. The curing process generally takes three 
hours. 
4.2 Optimization 
The appearance of perfect immediate ginseng chewable tablets is shown in Figure 4.2. 
For the core of ginseng chewable tablets, the tableting formulation was 40% ginseng 
powder, 58% mannitol and 2% magnesium stearate. For the coating process, HPC was 
used as the coating material, PEG 400 was selected as the plasticizer, the coating process 




Figure 4.2 The appearance of coated ginseng chewable tablets production 
4.2.1 Effects of tableting 
According to the provisions of the Chinese National Pharmacopoeia (CNP), the amount 
of ginseng per person per day should not exceed 3g. From the perspective of commercial 
products, each tablet should be 500mg in size and contain 40% ginseng content. 
Additives that may be used include sorbitol, mannitol, color, copovidone, colloidal 
silicon dioxide, and magnesium stearate. In the tableting process, the empirical amount of 
magnesium stearate is 0.5-2%, copovidone is 0-3%, and colloidal silicon dioxide is 1%. 
The preliminary tableting formulation is shown in the Table 4.1. 





Preliminary composition  
(wt%) 





magnesium stearate 0.5-2% 1% 
copovidone 0-5% 2.5% 




As mentioned before, the appropriate hardness is crucial for the subsequent coating 
process. For ginseng chewable tablets, a hardness level too high can make the chewing 
process very painful, thus affecting the taste. While a hardness level too low causes the 
tablet to be broken during the coating process. The ideal hardness is 60 N. The tablet 
formulation was modified to obtain a suitable tablet hardness. Note that both mannitol 
and sorbitol are sweeteners and their effects are similar, but overbearing amount of 
sorbitol can lead to diarrhea and digestive disturbances, so tablet hardness with different 
sorbitol content was tested. Three tablets were used for each hardness test and the 
average was taken as data. 
The content of ginseng powder was 40%, magnesium stearate was 1%, copovidone was 
2.5%, colloidal silicon dioxide was 1%, and the sum of mannitol and sorbitol was 55.5%. 
 
Figure 4.3 The effect of sorbitol content on hardness 
From the Fig. 4.3 we can see that the content of sorbitol has little relationship with the 
hardness. Under the premise of food safety, mannitol will be used as sweetener of 


















By improving the sweetener formulation, the chewable tablet hardness is still much 
greater than the target hardness. Because copovidone functions as a binder, it has the 
function of increasing the compressibility of the tablet and increasing the hardness. As a 
result, chewable tablets containing different levels of copovidone were used to test the 
hardness. Three tablets were used for each hardness test and the average was taken as the 
data. 
The copovidone content was 0-5%, therefore the difference between the maximum data 
and the minimum data was 5%. Compared to the low content of other additives 
(magnesium stearate was 1%, colloidal silicon dioxide was 1%) and the fixed content of 
ginseng powder (40%), the content of mannitol was higher, thus the error was relatively 
stable. The total content of mannitol and copovidone was 58% at a ginseng powder 
content of 40%. The effect of plasdone-S630 content on hardness can be seen in Fig. 4.4. 
 
Figure 4.4 The effect of plasdone-S630 content on hardness 
Higher copovidone content significantly increases the hardness of the tablet, so if the 




















Tablets must have sufficient lubricity to meet tableting needs. Magnesium stearate and 
colloidal silicon dioxide are all lubricants in the formulation, but colloidal silicon dioxide 
can be suspended in air. If it is not handled properly, it will cause harm to the 
experimenter. In addition, the price of colloidal silicon dioxide is much higher than that 
of magnesium stearate, which is an extremely important element in industrial production. 
Therefore, the formulation of magnesium stearate and colloidal silicon dioxide also needs 
to be improved. 
The way to characterize lubricity can be the through measurement of the angle of repose. 
However, each test required the use of 60 g sample, which would undoubtedly greatly 
increase the cost of the experiment. If the powder composing a tablet had poor lubricating 
properties, then vertical rubbing marks would form on the sides of the tablet. Therefore, 
in this experiment, the lubricating performance could be represented by the number of 
traces. If the lubricating performance was poor and could not be compressed into tablets, 
it was indicated by a cross (X). The result can be seen in Tablet 4.2. 
40% of the formula was ginseng powder, and the total weight of sweetener, magnesium 
stearate, and colloidal silicon dioxide was 60%. 
Table 4.2 The number of trace with different magnesium stearate (raws) and 
colloidal silicon dioxide contents (columns) 
 0% 0.5% 1% 1.5% 2% 
0% X X 3 2 0 
0.5% X X 3 2 0 
1% X X 3 0 0 
With 2% magnesium stearate, the mixed powder had good lubricity. At the same time, 
similar result was obtained when 1.5% of magnesium stearate was mixed with 1% of 
colloidal silicon dioxide. However, in view of the price of colloidal silicon dioxide which 
is far greater than that of magnesium stearate, in addition to taking the importance of cost 




Angle of repose 
Experiments had shown that the average angle of repose of the powder with 40% of 
ginseng, 58% of mannitol and 2% of magnesium stearate was 42.67°. Shown in Table 4.3. 
The coefficient of static friction (μs) of this mixed powder was 0.9218 (tan θ≈μs). 
Table 4.3 The result of angle of repose (40% of ginseng powder, 58% of mannitol 
and 2% of magnesium stearate) 
Number 1 2 3 
Angle of Repose 42.3° 42.8° 43.2° 
Average 42.67° 
tan 42.67°= 0.9218 
4.2.2 Effects of polymer 
Both hydroxypropyl cellulose (HPC) and Eudragit® E PO (EPO) are commonly used as 
immediate release materials. When comparing the two materials, it is seen that the film 
formed by EPO is denser than the membrane formed by HPC. However, the operating 
conditions of EPO are more complicated than that of HPC, and the amount of plasticizer 
and the plasticizer-coating material ratio need to be controlled more precisely.  
In addition, the EPO is much expensive than HPC. Because this experiment hopes to 
make a product that can be applied, the price factor cannot be ignored. HPC was used as 
an experimental coating material. 
4.2.3 Effects of temperature 
Although the treatment temperature can meet the requirements as long as the glass 
transition temperature of the film is satisfied, it is still important to select the appropriate 
processing temperature. A temperature too low will make the film less uniform and 




HPC was the coating materials and the coating temperature were 50 and 60°C. The ratio 
of the weight of the coating powder to the weight of the plasticizer and the coating levels 
are compared. The ratio of the weight of the plasticizer and the weight of the coating 
powder can be used to characterize the bonding potential of the tablet. 0.2 is considered 
an ideal value. The coating level is the ratio of the weight gain of the tablet during the 
coating process and the tablet itself. 
A certain weight of ginseng chewable tablets (5 tablets, each weighed 0.5 g) were mixed 
with 47.5 g of placebo tablets. The tablets were preheated to reach the target temperature, 
and subsequently coated with HPC and PEG 400. The final curing time was three hours 
until a smooth film was obtained. The result can be seen in Fig. 4.5. 
 
Figure 4.5 The effect of temperature on bonding potential 
In comparison to a higher temperature (60°C), a lower temperature ensured that the 
materials were in good condition. Therefore, the ginseng chewable tablet coating process 
















4.2.4 Effects of curing time  
The coating material of ginseng chewable tablets is HPC, which is a thermoplastic 
polymer and, thus, needs to be cured at a temperature exceeding the glass transition 
temperature for a certain period. 
An SEM of ginseng chewable tablets with different curing times (1,2 and 3h) can be seen 
in Figure 4.6. 
         
 
Figure 4.6 SEM of HPC coated ginseng chewable tablets with different curing time 
(coating level: 3%). (A) 1h, (B) 2h, (C) 3h 
The surface of the ginseng chewable tablet with only an hour of curing time was very 
rough, as some large powder particles can be observed. The ginseng chewable film with 
two hours of curing was relatively smooth, but had some visible bulges. After three hours 
of curing, the ginseng chewable film became very uniform. In the three figures, the 
surface of the film had some pores. Because it is immediate release coating, the influence 






4.2.5 Effects of coating level 
As mentioned above, the ideal formulation can be seen in Table 4.4, and the ideal 
operating conditions are shown in Table 4.5. 
Table 4.4 A selected formulation of ginseng chewable tablets 
Formulation Composition (wt%) 
ginseng powder 40% 
mannitol 58% 
magnesium stearate 2% 
 
Table 4.5 A select operating conditions for ginseng chewable tablets 
Condition Characterize 
polymer hydroxypropyl methylcellulose (HPMC) 
plasticizer polyethylene glycol 400 (PEG400) 
temperature 50℃ 
curving powder talc + ginseng powder 
curving time 3h 
 
Film formation is accomplished by the deformation and flow of the coating material. 
SEM was used to observe the relationship between coating levels and film formation. 
Four different coating levels were used for the study, which could be seen in Fig. 4.7.  




       
Figure 4.7 SEM of HPC coated ginseng chewable tablets with different coating 
levels (curing time: 3h). (A) 0%, (B) 1.5%, (C) 2%, (D) 3% 
The surface of the ginseng chewable tablets without a coating process was very rough. 
Without the protection of the film, and the ginseng chewable tablets were easily worn 
during the transportation process and collided with each other, resulting in changes to the 
appearance. The ginseng chewable tablets with a coating level of 1.5% had a film on the 
surface, but they were not fine enough and some independent particles could be seen. The 
films of ginseng chewable tablets with coating levels of 2% and 3% were very uniform, 
and it was difficult to see the pores, which was essential for the tablet’s resistance to the 
external environment. 
As an immediate release ginseng chewable tablet, there is currently no document defining 
how to characterize the chewing process. Therefore, chewable tablets with different 
coating level were divided into four pieces to simulated human chewing behavior. To 
facilitate the detection of dissolution, 2% of the water-soluble pigment was added to the 
formulation of ginseng chewable tablets while reducing the mannitol content by 2%. The 
results showed that the ginseng chewable tablets with 2% color did not differ from the 
original ginseng chewable tablet in terms of hardness and selectivity to the coating 
material. 
The ginseng chewable tablets were placed in 900 mL of water at a constant temperature 





Figure 4.8 The effect of coating level on release time (curing time: 3h) 
Evidently, there was no significant difference in the duration of the ginseng chewable 
tablets of the three different coating levels. If no other factors are taken into consideration, 
ginseng chewable tablets with 1.5% coating level is optimal use for production. 
Coatings of ginseng chewable tablets increase the resistance of the tablets to the external 
environment, such as the wear due to collisions. Therefore, different coating levels of 
ginseng chewable tablets were placed in a small bottle (10cm in length and 3cm in 
diameter), each bottle held 5 pieces of tablets, the bottle was then rocked up and down at 
a frequency of 60 times per minute for 5 mins, and the wear rate was examined. The wear 
rate is the ratio of the reduced mass of chewable tablets to the original mass. The greater 
the wear rate, the more susceptible the tablet was during a collision. Three trails were 
performed for each coating level and the average was taken. The effect of coating level 































Table 4.6 The effect of coating level on wear rate for ginseng chewable tablets 





The ginseng chewable tablets with 2% and 3% coating level did not wear within five 
minutes, but the ginseng chewable tablets at 1.5% coating level wore 0.31% within the 
same time. Although this figure is much smaller than the 3.27% without the coating, in 
view of the longer duration of transportation, 2% or 3% coating levels will be selected for 




Chapter 5  
5 Plasticizer-assisted Powder Coating of Amino Acid 
Pellets 
5.1 Apparatus and experimental procedures 
5.1.1 Apparatus 
Coating pans suitable for specific amino acids pellets are similar to coating pans for 
ginseng chewing tablets. A schematic diagram of the rotating coating pan can be seen in 
Fig. 5.1. As described above, a large incubator is thermostatic, where outside of the 
coating pan is a circle with a diameter of 12.8 cm and a depth of 12.8 cm. There are four 
prisms inside the coating pan. The irregular movement of the coating pan promotes the 
rolling of particles, making the coated film more uniform. Due to the small weight of the 
amino acid pellets, it is necessary to avoid the effects of gas as much as possible. The 
liquid plasticizer spray system includes a metering pump and an atomizing nozzle that 
requires the participation of gas. To avoid the use of a gas, the powder feed is hand-
poured as the specific surface area of the amino acid particles is large enough, and the 
distribution of the powder after rolling in the particles is relatively even. In addition, there 
is a cover on the outside of the rotating coating pan to prevent pellets from flying out of 
the pan when the plasticizer is sprayed. 
 
Figure 5.1 The schematic of rotating coating pan for amino acid pellets  
(A) Liquid plasticizer spraying system. (B) Rotating coating pan. 
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5.1.2 Experimental procedures 
Just as the process of coating the ginseng chewing tablets, the preparation of coating 
amino acid pellets also requires five steps—preparing the coating powder, preheating the 
pellets and equipment, spraying the liquid plasticizer, spraying the powder, and curing. 
The first step is to prepare the coating powder. Ethyl cellulose (EC) was selected as a 
sustained release material. The addition of lactose which was the solid plasticizer made 
the film denser and reduced the amount of liquid plasticizer. The addition of talc reduced 
the adhesion between the particles. 
The second step was to place 50 g of amino acid pellets into the rotating coating pan, set 
the temperature above the glass transition temperature, and pre-heated at a lower rotation 
speed. 
The speed was then increased to avoid tablet surface adhesion when spraying plasticizers 
and coating powders. Plasticizer (triethyl citrate (TEC)) was sprayed for a period of time 
immediately followed by the spraying of a certain amount of powder and a reduction of 
speed. These two steps usually need to be repeated several times every 10-20 minutes. 
The curing step begins when a sufficient amount of coating material has adhered to the 
pellets surface. To prevent adhesions, talc powder was added. The curing process usually 
took three hours. 
5.2 Optimization 
From the cost perspective, the total ethyl cellulose (EC) content need to be reduced to 6% 
weight on the pellets, the release time of amino acid particles can be up to 2 to 3 hours 
and the coating film is sufficiently uniform. The EC content is affected by the coating 
level and the proportion of EC in the powder material. Therefore, the optimization 
process of the amino acid pellets includes, optimizing of the coating level and the 
formulation, and under appropriate conditions, further optimization of the other factors. 
49 
 
The release profile of a successful EC coated sustained release amino acid pellet is shown 
in Figure 5.2. The formulation of the coating powder is 20% EC, 50% talc and 30% 
lactose. The curing time is 3 hours and coating level is 30%. 
 
Figure 5.2 The release profile of EC coated sustained amino acid pellets product 
(Coating powder formulation: 20% EC, 50% talc and 30% lactose.  
Coating level: 30%. Curing time: 3h) 
5.2.1 Effects of coating level 
Commonly used coating materials are mixtures of EC, lactose and talc in a certain 
proportion. EC is the key polymer for film formation. Lactose is a solid plasticizer that 
reduces the amount of liquid plasticizer and inhibits the deposition of the main plasticizer. 
Talc can significantly reduce the adhesion between particles themselves and between 
particles and walls. Usually, in an ideal formulation, the weight ratio of talc to lactose is 
between 1:2 and 1:3. 
By adjusting the amount of plasticizer used and the amount of coating powder used, it 
was ensured that the particles did not stick together during the coating process and the 























The release profiles of the amino acid granules for the three different formulas (see Table 
5.1) and the different coating levels can be seen in Figure 5.3. 
Table 5.1 The coating powder formulation for different series of amino acid pellets 
Series EC  Lactose Talc 
1 80% 15% 5% 
2 60% 25% 15% 
3 40% 40% 20% 
 
 
Figure 5.3 The effect of coating level on release time with different EC content. 
(Curing time: 3h) 
Higher coating levels tend to lead to longer release times. If the weight of the raw 
material of amino acid pellets is constant, achieving a higher coating level requires more 
plasticizer, more steps, and a longer curing time between each step. Therefore, the 
formed film will be more uniform to some extent. The SEM images of amino acid pellets 
























       
 
Figure 5.4 SEM of EC coated amino acid pellets with different coating level  
(Coating powder formulation: 40% EC, 20% talc and 40% lactose. Curing time: 3h). 
(A) 17.04%, (B) 19.17%, (C)27.95% 
The film with 17.04% coating level had some pores and the surface of the film was 
uneven. The film with 19.17% coating level was relatively uniform, but there were still 
some pores. However, the film at 27.95% coating level was very uniform and it was 
difficult to see the pores. The release time of these three samples were 105 minutes, 135 
minutes and 400 minutes, respectively. 
In general, the coating level and the release time were exponential, and a higher coating 
level would result in a longer release time. For the release profiles that met the 
requirement of 120~180 minutes, coating level could be as low as 18% for a powder 
containing 60% EC by weight, and about 27% for a powder containing 40% EC by 
weight. For the powder containing 80% by weight of EC, this value needed to reach 35%. 
However, all three had a significant increase when the coating level was 30%. Therefore, 





5.2.2 Effects of formulation 
The effect of net EC content on release time could be seen in Fig. 5.5. It was clear that 
none of these three formulation powders met the requirement of a net EC weight of 6%. 
However, when EC content was in the range of 40%, 60%, and 80%, if the EC content 
was lower, and the curve shifted to the upper left of the graph (lower EC content and 
longer release time). This also gave us the reason to believe that reducing the EC content 
to 20% was likely to have better results. 
 
Figure 5.5 The effect of net EC content on release time. (Curing time: 3h) 
According to the relationship between the coating level and the release time, a 30% 
coating level could often bring about better result. In accordance with the premise (Net 
EC<=6%), formulations containing 20% EC by weight were considered. 
As a rule of thumb, 20% by weight of EC, 25% by weight of talc and 55% by weight of 
lactose were first used for coating. The dissolution curve could be seen in Figure 5.6. The 

























Figure 5.6 The release profile of amino acid pellets. (Coating powder formulation: 
20% EC, 25% talc and 55% lactose. Coating level: 30%. Curing time: 3h) 
 
Figure 5.7 SEM of EC coated amino acid pellets. (Coating powder formulation: 20% 
EC, 25% talc and 55% lactose. Coating level: 30%. Curing time: 3h) 
The formulation of 20% EC, 25% talc and 55% lactose did not meet the requirements. 
Under the premise that the EC content was 20%, the ratio of talc and lactose was adjusted. 



























Figure 5.8 The effect of talc content on release time  
(Coating level: 30%. Curing time: 3h) 
Under the premise that the EC content is 20%, the ratio of talc and lactose had a great 
influence on the release time. In the case of 50% talc and 30% lactose, the release time 
reached 150 minutes. However, this did not correspond to the weight ratio of 1:2 to 1:3 
for the talc and lactose in the normal case. The amount of EC content was likely to have 
an impact on the empirical formula. The SEM of amino acid production could be seen in 
Fig. 5.9. 
   
Figure 5.9 The SEM of EC coated amino acid pellets （Coating powder formulation: 




















5.2.3 Effects of the plasticizer-powder ratio 
Under the precondition that both films were uniform and amino acid pellets were as moist 
as possible, the ratio of plasticizer and powder represented the possibility of film 
formation during the coating process. The higher this ratio was, the easier it was to form a 
uniform film; the lower the ratio, the higher the amount of powder particles present on 
the surface resulting in a brittle film. 
According to the ratio of the amount of EC, powder formulations was divided into two 
types. One is too much or too little EC. If EC content was too much, the powder stuck to 
the surface more easily without forming a film, resulting in a more brittle film, which 
required more plasticizers to make up for this shortcoming.  
In the case where the coating level was approximately 30%. If EC content is too little, an 
uneven film will form due to the lack of polymers, which could be compensated by 
increasing the coating level. Therefore, the relationship could be seen in Figure 5.10. 
Another situation is that the EC was at a suitable amount. The higher the EC content was 
and more the plasticizers were provided, the easier to form a uniform film, which can be 
seen in Fig. 5.11. Coating potential was defined as the product of the plasticizer-powder 
ration and coating level for higher or lower EC content series formulation and as the 





Figure 5.10 The effect of the coating potential on the release time (EC content:80%) 
 
Figure 5.11 The effect of the coating potential on the release time  
(EC content: 40% and 60%) 
From the two figures above, it could be seen that when the EC content was 40% and 60%, 
the release time was more related to the ratio of plasticizer and powder and the net EC 
content. When the product of the ratio and the net EC content was about 3, the release 







































At the same time, when the EC content was 80%, the release time was related to the ratio 
of plasticizer and powder and the coating level. When the product of the ratio and the 
coating level was approximately 9, the release time could be made to be 150 minutes. 
This conclusion could also be applied to the formulation of 20% EC. When the coating 
level was 30%, the ratio of plasticizer to powder was 0.286 and the release time was 150 
minutes. The product in this process was 8.6, which was about 9. 
5.2.4 Effects of curing time 
In dry powder coating technology, most polymers are thermoplastic materials. When the 
curing temperature exceeds the glass transition temperature of the polymer, the 
thermoplastic polymer forms a thin film. The curing process is critical to the uniformity 
of the film. This process requires a certain amount of time. 
At 55°C, curing results were shown in Fig. 5.12 with four intervals (0h, 1h, 2h, 3h). SEM 
was used to demonstrate the effect of curing time on the film. 
 




      
Figure 5.12 SEM of EC coated amino acid pellets with different curing time 
(Coating powder formulation: 20% EC, 50% talc and 30% lactose.  
Coating level: 30%). (A) 0h, (B) 1h, (C) 2h, (D) 3h 
As shown in the Figure 5.12, when the curing process started, at the 0h, there were many 
particulates on the surface of the amino acid pellets, and the powder particles were 
independent of each other and no film was formed. This resulted in a very uneven surface 
of the amino acid pellets and some pores on the surface. At 1h, the powder particles 
began to fuse with each other, but the amino acid surface was still not smooth enough and 
consisted of some pores, and the particles were still somewhat independent of each other. 
At the second hour, a film made of a polymer material was already visible, the powder 
particles had already merged into one another, but there was still a small presence of 
pores. In the third hour, there were few pores and the membrane was more uniform. 
The release time of amino acid pellets with different curing time could be seen in Figure 
5.13. From the SEM image, the films which had been cured for two or three hours had a 
good homogeneity, so their release time was about 150 minutes. The release time of the 
amino acid pellets with one hour of curing time was 135 minutes, and there were some 
pores in the film. The surface of the amino acid pellets that had not undergone the curing 
process were very uneven, so the release time was only 120 minutes. The curving process 
could increase the release time of the amino acid pellets to a certain extent. However, due 
to the curing time between each injection, the amino acid pellets have had a film and a 





Figure 5.13 The effect of curing time on release profile (Coating powder formulation: 
20% EC, 50% talc and 30% lactose. Coating level: 30%) 
As a product, appearance is also a very important factor. The appearance of different 
curing time amino acid pellets can be seen in Figure 5.14. 
 
























      
Figure 5.14 The appearance of EC coated amino acid pellets with different curing 
time (Coating powder formulation: 20% EC, 50% talc and 30% lactose.  
Coating level: 30%). (A) 0h, (B) 1h, (C) 2h, (D) 3h 
The amino acid pellets that had not undergone the curing process were blue and off-white. 
By increasing time, the blue color of the amino acid pellets became brighter and the 
appearance became more and more appealing. Therefore, a curing period of three hours 







Chapter 6  
6 Scale-up Experiments for Amino Acid Pellets 
6.1 Introduction 
Ningbo Wesdon Powder Pharma Coatings Co., Ltd. is located in the Ningbo New 
Material Innovation Zone of Ningbo National High-tech Zone, Zhejiang Province. As a 
high-end entrepreneurship and innovation team in Ningbo, Wesdon Coating Technology 
has obtained funding from the government's “3315 Plan” of 10 million yuan for the 
promotion of efficient and environmentally friendly ultra-fine powder dry drug coating 
technology and equipment.  
At present, pharmaceutical companies generally adopt wet film coating technology to 
coat solid pharmaceutical preparations. However, due to the requirement of heat, the 
evaporation of organic solvents or water occupies a large portion of the total cost. 
Additionally, to obtain a smooth and uniform coating surface, several hours or even days 
are required for curing. Wesdon applied the ultra-fine powder electrostatic spraying 
technology to pharmaceutical preparations for the first time, fundamentally solving the 
limitations of wet coating, which is a huge innovation. The dry powder coating 
technology sprays the micronized coating material on the surface of the drug and melts it 
to form a uniform and dense functional coating. The project has successfully completed 
the 50kg scale test. The dry coating technology, in comparison with wet coating, offers 
the benefits of a simpler solvent treatment, lower energy consumption and lower costs. 
Furthermore, the technology can potentially produce osmotic pumps and biological 
products with antimicrobial coatings. 
6.2 Objectives 
The main purpose of this project is to scale up the coating process of 50g-scale sustained 
release amino acid pellets to the scale of 800g. 
First, amino acid pellets can be released slowly in water for two hours. Second, optimize 




Talc powder was from Bulk Pharmaceutical Chemical. Lactose (Tablettose® 80) was 
bought from Meggle Pharma - Excipients & Technology. Ethyl cellulose (EC) was 
bought from Xiaolun (Zhejiang) Pharmaceutical Machinery Co., Ltd. Triethyl citrate 
(TEC) was from EMD Millipore Corporation (Germany). 
6.4 Methods 
6.4.1 Particle size reduction 
In general, smaller diameter particles are more expensive than larger diameter particles. 
In larger scale experiments, due to more demand for particles and taking into the factor of 
cost, particles with large particle sizes are often purchased, and the required small size 
particles are obtained after jet mill treatment. A typical pilot-scale jet mill is shown in 
Figure 6.1, which can smash 1.5 kg 300 microns ethyl cellulose (EC) to less than 50 
microns EC in one hour. 
 
Figure 6.1 The schematic of jet mill 
6.4.2 Powder mixing 
In the coating of amino acid pellets of 50g scale, it was usually necessary to dispose 20g 
of coating powder, so a small stirrer could meet the demand. However, for the 800g-scale 
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amino acid pellets coating experiment, a larger V-shaped stirrer (shown in Fig. 6.2) is 
used to ensure complete mixing for the larger batch size. 
 
Figure 6.2 The schematic of V-shaped stirrer 
6.4.3 In-vitro drug release testing 
In-vitro drug release profiles of the coated samples were tested by the United States 
Pharmacopeia (USP) apparatus (Apparatus 2, paddle; TDTF ZRS-8GD, Tianjin, China). 
For the EC coated amino acid pellets, the drug release medium is 1000 mL of pure water 
maintained at 37°C with a 50 RMP paddle rotation speed. 
In this process, 10 mL of the sample was collected using a 10mL syringe over a certain 
period, and 10 mL of fresh medium (pure water) was immediately supplemented. After 
10 mL of the sample was filtered, it was analyzed with a UV-Visible spectrophotometer. 
The maximum absorption wavelength of the analyzed component of the amino acid pellet 
was 194 nm. 
The drug dissolution profiles of amino acid pellets can be seen in Figures 3.1. The curve 




Figure 6.3 Standard curve of amino acid pellets 
After the creation of the standard curve of amino acid pellets, a precision test, accuracy 
test and a stability test are required for the acceptability validation of the application of 
UV-vis spectrophotometer that is used for the measurement and analysis of the drug 
release from amino acid pellets. The method of processing is the same as that in section 
3.7.2. 
6.5 Scale-up experiments of plasticizer-assisted powder 
coating of amino acid pellets 
6.5.1 Apparatus  
Compared with the small rotating coating pan in the Western University laboratory, 
Wesdon's large-scale rotating coating pan has been greatly improved. Generally, the 
rotating coating pan is heated by gas, and hot air enters the incubator from the upper part 
and exits from the lower part of the incubator. The liquid plasticizer spray system 
includes a metering pump and an atomizing nozzle. The powder spraying system includes 
a nozzle and a feeder. The atomizing nozzle and the powder nozzle are placed in the 
























Concentration of amino acid pellets (ppm)
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middle of the coating pan. The entire coating pan is nearly cylindrical with oppositely 
oriented edges inside, which promotes the rolling of the pellets. The schematic of rotating 
coating pan is shown in Fig. 6.4. 
 
 
Figure 6.4 The schematic of rotating coating pan for scale-up experiments.  
(A) Liquid nozzle. (B) Powder nozzle. (C) Air inlet. (D) Air outlet. 



























6.5.2 Experimental procedures 
The process of coating the sustained release amino acid pellets with a rotating coating 
pan is divided into four parts including: preparing the coating powder, preheating the 
pellets and equipment, concurrently spraying the plasticizer and the coating material and 
curing. 
The first step is to prepare the coating material for the pellets. Ethyl cellulose (EC), 
lactose, talc, and certain pigments are mixed into a uniform formula until no 
agglomeration or color difference occurs. Relative to the 50g scale experiment, the 800g 
scale experiment requires the use of special equipment (V-shaped stirrer) for mixing. 
Various materials were placed in a V-shaped stirrer and mixed at a constant rate for 15 
minutes before being removed. 
The second step is to put 800g of amino acid pellets into the rotating coating pan, set a 
certain intake temperature (to ensure the temperature of the outgoing gas exceeds the 
glass transition temperature) and rotate the coating pan at a slow speed.  
Next, the rotational speed of the coating pan is increased to avoid adhesion of amino acid 
pellets and pan. Since the total volume of amino acid pellets is large, they will be stacked 
in the pan. Due to this, the liquid plasticizer and coating the powder are to be sprayed 
concurrently to promote a consistent coat among the pellets. The two nozzles are to be 
controlled in the central of the coating pan, which avoids the polymerization of 
plasticizers and coating powders in the free zone of the pan. The speed is reduced for 10 
minutes then the third step is to be repeated. 
The curing step begins when there is a sufficient amount of coating material on the 
surface of the amino acid pellets. To prevent adhesion, this step usually requires the 
addition of a certain amount of talc. Due to the stack of amino acid pellets, gravity 
promotes the curing of the pellets. Therefore, the 800g amino acid pellets curing process 





Effect of powder efficiency 
In small-scale experiments, powder efficiency is often overlooked. To some extent, some 
materials are abused to get the best result, however, in the industrial production, the cost 
is the key factor that is taken into consideration. Therefore, the efficiency of powdered 
products must be optimized first. 
To completely bind the liquid plasticizer and coating powder to the amino acid pellets, 
the coating pan has a higher linear velocity, a greater atomization degree of the liquid 
plasticizer, and a larger spray rate of the coating powder. These factors can cause a 
portion of the amino acid pellets to fall out of the coating pan. A portion of the liquid 
plasticizer and the coating powder flow out with the gas in the incubator. In order to 
improve this deficiency, a plastic pad was installed on the inlet of the coating pan and the 
plastic pad was fixed with the nozzle. The improved rotating pan is shown in Fig. 6.5. 
 
Figure 6.5 The schematic of improved rotating coating pan for scale-up experiments. 
(A) Liquid nozzle. (B) Powder nozzle. (C) Air inlet. (D) Air outlet. (E) Powder feeder. 
(F) Air pump. (G) Metering pump. (H) Plastic pad. 
According to the same procedure, 240g of the coating material and 60g of the liquid 











and a coverless coating pan, respectively. The powder efficiency is shown in Fig. 6.6, and 
the final product is shown in the Fig. 6.7. 
 
 




Figure 6.7 The appearance of EC coated amino acid pellets (With after curing).  














Effect of the amount of plasticizer 
As mentioned previously, the ratio of plasticizer and powder represents the possibility of 
film formation during the coating process. The higher this ratio is, the easier it is to form 
a uniform film; the lower the ratio, the higher the amount of powder particles present on 
the surface resulting in a brittle film. 
For this experiment, the surface of 800g of amino acid pellets needs to be sprayed with 
240g of the coating material, corresponding to a 30% net coating level. Therefore, 
different amounts of plasticizers were used to find the most suitable release time. Under 
the same experimental procedure, the surface of the amino acid particles is uniformly 
sprayed with plasticizer at a constant speed. The weight of the liquid plasticizer was 
chosen as 60g, 80g and 100g. The corresponding dissolution time is shown in the Fig. 6.8, 
and the appearance of the corresponding product is shown in the Fig. 6.9. 
 
 






















Figure 6.9 The appearance of EC coated amino acid pellets with different amounts 
of plasticizer (With after curing). (A) 60g. (B) 80g. (A) 100g. 
Effect of the plasticizer flow rate  
When 80g of liquid plasticizer is used, the amino acid pellets have the longest release 
time. However, the 90 minutes release time does not meet the 120 minutes release time 
requirement. It is noted that during spraying, more liquid plasticizer will benefit the 
formation of a dense film on the surface of the amino acid pellets, however, too much 
plasticizer will cause the amino acid pellets stick together, resulting in a reduction of the 
release time. Therefore, an improved method is spray the liquid plasticizer at a lower 
flow rate while the total weight of the liquid plasticizer is unchanged. Using 60g of liquid 
plasticizer, the original and post-improvement release times are shown in Figure 6.10. 




Figure 6.10 The effect of the way of spraying plasticizer on release time 
(Plasticizer:60g. With after curing). 
Effect of after curing 
In general, during the production of dry powder coated solid preparations, the solid 
preparations need to be cured in an incubator for a certain period in addition to the curing 
process in the coating pan. In the small-scale experiment, there was no significant 
difference between the amino acid pellets that had undergone the incubator curing 
process and the amino acid pellets that had not undergone the curing process in the 
incubator. In this experiment, given the 800g of amino acid pellets and 240g of coating 
powder, two release profiles of amino acid pellets using 60g liquid plasticizer and 80g 














Figure 6.11 The effect of curving on release profile  
(A): 60 g plasticizer (B): 80g plasticizer 
For amino acid pellets using 60g plasticizer, the release speed was accelerated after the 
curing process in the incubator. For amino acid granules using 80g plasticizer, the curing 
process in the incubator retarded the release rate. 
A reasonable explanation is that when more liquid plasticizer was used, the amino acid 















































film on the surface of the pellets. However, if there was less liquid plasticizer, there 
would be some pores on the surface of the amino acid pellets, which would increase the 
cracks of the film to a certain extent during the curing process in the incubator, thereby 
reducing the release time. The appearance of the original amino acid pellets with 60g 
plasticizer and the amino acid pellets with 60g plasticizer that had undergone curing in 
the incubator can be seen in Figure 6.12. After the curing process, the color of the amino 
acid pellets became lighter and the film was relatively more fragile. 
 
Figure 6.12 The appearance of EC coated amino acid pellets with 60g plasticizer.  




Chapter 7  
7 Conclusions 
Coating products based on dry powder coating technology platform were produced 
successfully. Immediate release of ginseng chewable tablets using electrostatic powder 
coating technology ensures that the product has a certain degree of wear resistance and 
aesthetics with an immediate release in 5 minutes. The sustained release amino acid 
pellets using the plasticizer-assisted powder coating technique achieved a sustained 
release in 2-3 hours. 
For ginseng chewable tablets with immediate release coating, in the process of tableting, 
for the lubricity of the mixed powder and the hardness of the chewable tablets, different 
kinds of the tableting materials with various ratio are investigated. The optimal tableting 
formulation was found to be 40%wt of ginseng powder, 58%wt of mannitol and 2%wt of 
magnesium stearate, where sufficient lubricity of the mixed powder can be achieved, and 
the tablet hardness was stabilized at 60N. 
In the process of coating immediate release ginseng chewable tablets, coating materials, 
coating temperature, curing time and coating level were used to investigate. The best 
conditions were found to be using HPC as a coating material, PEG 400 as a plasticizer, 
coating at 50°C and curing for 3 hours. By SEM micrographs, a uniform firm was formed 
on the surface of chewable tablets with 2% and 3% coating levels. In the case of 
simulated chewing, immediate release of ginseng chewable tablets achieved complete 
release within 7 minutes. As a product, the immediate release ginseng chewable tablets 
with coating have a good appearance and considerable wear resistance. 
For amino acid pellets with sustained release coating, SEM micrographs show that pellets 
with higher coating levels exhibit a better film smoothness. With a given formulation, the 
in-vitro drug release test showed pellets having a higher level of the coating can have a 
longer sustained release time. In addition, the composition of EC in the coating material 
is essential for the sustained release coating process. As a product, sustained release 
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amino acid pellets with a longer curing time (3h) have a better smoothness from SEM 
micrographs, and at the same time as a commodity, have a better appearance. 
In the 800g-scale experiment of sustained release amino acid pellets, for a given net 
coating level of 30%, 80g liquid plasticizers can be used, the plasticizer flow rate can be 
slower. The produced amino acid pellets of this coating level are placed in an incubator 
for a certain period to meet the two-hour release time requirement. 
In summary, the dry powder coating technology can be well applied to the immediate 
release ginseng chewable tablets and sustained release amino acid pellets. Those 
laboratory studies provided new opportunities for additional potential commercial 
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Appendix A. Example of Error analysis 
It is necessary to ensure that the experimental error is within a certain confidence interval. 
Thus, some typical experiments are selected for analysis.  
The example of the effect of coating level on hardness of ginseng chewable tablets with 
error bars can be seen in Fig. A.1. These results are repeated for three times. For the 
ginseng chewable tablets of 2% coating level, at 3 minutes, the cumulative release data 
for three experiments is 70.2, 71.3 and 69.4, respectively. The mean of these three data is 
70.3 and the standard deviation of the data is 0.95. In addition, these three data are within 
the 95% confidence interval. Thus, the data is acceptable. 
 
Figure A.1 The effect of coating level on release time (curing time: 3h) 
The error bars of the effect of curing time on release profile for amino acid pellets 
(Coating powder formulation: 20% EC, 50% talc and 30% lactose. Coating level: 30%) 
are shown in Fig. A.2. These results are repeated for three times. For the ginseng 





























three experiments are 61.4, 62.6 and 61.8, respectively. The mean of these three data is 
62.3 and the standard deviation of the data is 0.76. In addition, these three data are within 
the 95% confidence interval. Thus, the data is acceptable. 
 
 
Figure A.2 The effect of curing time on release profile (Coating powder formulation: 
20% EC, 50% talc and 30% lactose. Coating level: 30%) 
These analyses show that the experimental errors of this type experiments are small. 
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